Vivo has reduced prices of the T3 Ultra and T3 Pro by ₹2,000, positioning both under ₹30,000. The T3 Pro now starts at ...

Poco has launched its X series smartphones in India, competing in the sub ₹30,000 segment against OnePlus Nord 4 and Vivo T3 ...

The Motorola Edge 50 Neo gets a Rs 9000 discount on Flipkart, which brings its price down to Rs 20,999. Along with that, it can also be bought using some additional bank discounts such as Rs 1000 ...

China's Vivo has announced a price cut for all variants of its Vivo T3x 5G smartphone. The smartphone is now available, starting at Rs 12,499 in the Vivo India e-store, e-commerce platform Flipkart, ...

Call it the Redmi 14C 5G launch effect. Vivo has announced a price cut on its popular T3x 5G smartphone, a few days before the launch of Xiaomi’s budget competitor. Vivo T3x 5G price in India ...

At their peak in April, prices for the ingredient surpassed $12,000 per tonne, which was an almost threefold increase from January, the FT reported. Cocoa prices have soared due to poor climate ...

National house prices were down by 0.17 per cent in December, according to the latest data from PropTrack. However the small decline has done little to curb the market’s overall upward ...

The vivo T3x 5G now costs Rs. 12,499 for the 4GB + 128GB model, 6GB + 128GB model costs Rs. 13,999 and the 8GB + 128GB model is priced at Rs. 15,499, after the price cut. The phone is now available at ...

At this price, you definitely won’t get to see more ... under ₹20,000 are the Redmi Note 12 Pro, Realme 10 Pro, Vivo T1, Samsung Galaxy M14, and Moto G71.

For more financial news, go to the News24 Business front page. Rolex SA, the biggest luxury Swiss watch brand, raised prices on some of its most popular models after gold values surged in 2024. The ...

The Redmi 14C 5G is confirmed to come with a premium Starlight design inspired by the beauty and power of the cosmos. The smartphone will feature a 6.88-inch HD+ display with a 120Hz refresh rate.

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer PFE.N COVID-19 treatment Paxlovid, Bristol Myers Squibb's BMY.N cancer cell therapies and vaccines ...